Can biochemical markers predict bone loss at the hip and spine?: A 4-year prospective study of 141 early postmenopausal women

被引:56
作者
Keen, RW
Nguyen, T
Sobnack, R
Perry, LA
Thompson, PW
Spector, TD
机构
[1] ST THOMAS HOSP, DEPT RHEUMATOL, LONDON SE1 7EH, ENGLAND
[2] ST VINCENTS HOSP, GARVAN INST MED RES, SYDNEY, NSW 2010, AUSTRALIA
[3] ROYAL LONDON HOSP, LONDON E1 1BB, ENGLAND
[4] ST BARTHOLOMEWS HOSP, LONDON, ENGLAND
基金
英国惠康基金;
关键词
biochemical assay; bone densitometry; bone turnover; menopause; osteoporosis;
D O I
10.1007/BF01623014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A number of recent studies have suggested that non-invasive measures of bone turnover are associated with bone loss at the forearm in postmenopausal women. Whether bone turnover markers are predictive of bone loss from the clinically important sites of lumbar spine and femoral neck remain unclear, and was the aim of this 4-year prospective study. One hundred and forty-one normal, postmenopausal women (mean age 52.0 +/- 3.3 years, mean menopause duration 20.4 +/- 5.7 months) were recruited for the study in 1988. Fasting early morning samples of blood and urine were collected at the baseline visit and stored at -20 degrees C prior to analysis. Serum was assayed for osteocalcin, oestradiol, oestrone, oestrone sulphate, testosterone, sex hormone binding globulin, dehydroepiandrosterone sulphate and total alkaline phosphatase. Urine was assayed for calcium, hydroxyproline, oestrone glucuronide and the collagen cross-links pyridinoline and deoxypyridinoline using high-performance liquid chromatography. Bone density was measured at the lumbar spine and femoral neck using dual photon absorptiometry at time 0, 12, 24 and 48 months. The mean annual percentage change in bone density (SE) was -1.41% (0.18) at the lumbar spine and -0.86% (0.22) at the femoral neck. There was no evidence of bimodality or a fast loser subgroup as the rates of change were normally distributed. Both simple and multiple stepwise regression analyses revealed no significant correlation between the rates of change in bone density with any biochemical marker, either individually or in combination, despite the study having sufficient power (80%) to detect a correlation of 0.5 between any biochemical marker levels and bone loss. We conclude that single measurements of these markers of bone turnover and endogenous sex hormones appear unlikely to be clinically useful in predicting early postmenopausal bone loss from either the spine or the hip.
引用
收藏
页码:399 / 406
页数:8
相关论文
共 31 条
[1]   QUANTITATIVE-ANALYSIS OF THE PYRIDINIUM CROSSLINKS OF COLLAGEN IN URINE USING ION-PAIRED REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
BLACK, D ;
DUNCAN, A ;
ROBINS, SP .
ANALYTICAL BIOCHEMISTRY, 1988, 169 (01) :197-203
[2]  
CHRISTIANSEN C, 1987, LANCET, V1, P1106
[3]  
CHRISTIANSEN C, 1993, P 4 INT S OST, P52
[4]   APPENDICULAR BONE-DENSITY AND AGE PREDICT HIP FRACTURE IN WOMEN [J].
CUMMINGS, SR ;
BLACK, DM ;
NEVITT, MC ;
BROWNER, WS ;
CAULEY, JA ;
GENANT, HK ;
MASCIOLI, SR ;
SCOTT, JC ;
SEELEY, DG ;
STEIGER, P ;
VOGT, TM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (05) :665-668
[5]   BONE-DENSITY AT VARIOUS SITES FOR PREDICTION OF HIP-FRACTURES [J].
CUMMINGS, SR ;
BLACK, DM ;
NEVITT, MC ;
BROWNER, W ;
CAULEY, J ;
ENSRUD, K ;
GENANT, HK ;
PALERMO, L ;
SCOTT, J ;
VOGT, TM .
LANCET, 1993, 341 (8837) :72-75
[6]  
DAVIS JW, 1992, J BONE MINER RES, V7, P719
[7]   A CONTROLLED TRIAL OF THE EFFECT OF CALCIUM SUPPLEMENTATION ON BONE-DENSITY IN POSTMENOPAUSAL WOMEN [J].
DAWSONHUGHES, B ;
DALLAL, GE ;
KRALL, EA ;
SADOWSKI, L ;
SAHYOUN, N ;
TANNENBAUM, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (13) :878-883
[8]   NYCTOHEMERAL CHANGES IN BONE TURNOVER ASSESSED BY SERUM BONE GLA-PROTEIN CONCENTRATION AND URINARY DEOXYPYRIDINOLINE EXCRETION - EFFECTS OF GROWTH AND AGING [J].
EASTELL, R ;
SIMMONS, PS ;
COLWELL, A ;
ASSIRI, AMA ;
BURRITT, MF ;
RUSSELL, RGG ;
RIGGS, BL .
CLINICAL SCIENCE, 1992, 83 (03) :375-382
[9]   COMPARISON OF NEW BIOCHEMICAL MARKERS OF BONE TURNOVER IN LATE POSTMENOPAUSAL OSTEOPOROTIC WOMEN IN RESPONSE TO ALENDRONATE TREATMENT [J].
GARNERO, P ;
SHIH, WCJ ;
GINEYTS, E ;
KARPF, DB ;
DELMAS, PD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) :1693-1700
[10]   ROLE OF PEAK BONE MASS AND BONE LOSS IN POSTMENOPAUSAL OSTEOPOROSIS - 12 YEAR STUDY [J].
HANSEN, MA ;
OVERGAARD, K ;
RIIS, BJ ;
CHRISTIANSEN, C .
BMJ-BRITISH MEDICAL JOURNAL, 1991, 303 (6808) :961-964